Open Accessibility Menu


Pneumonia Vaccination and Protection Against Community Acquired Pneumonia

Status: Active/Enrolling

This pneumonia vaccination study determines the effectiveness of Pfizer’s Prevnar 20 pneumonia vaccine against pneumococcal pneumonia in comparison to other pneumonia vaccines. Prevnar 20 helps protect against more strains of bacteria that cause pneumonia.

Primary Investigator: Dr. Christian Tomaszewski/Sub-Investigators: Dr. Jorge F. Robles

You may be eligible if:

  • You are admitted to the hospital with pneumonia.
  • Male or female, age 65 and older.

Benefits of Participating: The knowledge that you are helping others.

Participation Details:

  • A urine specimen will be collected once during hospital stay.